Breast Cancer Clinical Trials in New York

Showing 421-422 of 422 trials

Infrared Imaging (Breast Scan IR) for Early Breast Cancer Detection

NCT00195026

This protocol will evaluate a new non-invasive infrared imaging system as an adjunctive tool for breast cancer detection that has been approved by the FDA. The technology and device have been developed by Infrared Sciences Corp. and has undergone more than 3 years of testing prior. The subject device's utility will be investigated with regard to its sensitivity toward breast cancer, however it records temperature data and other physiological parameters of the breast, and compares them to a database of patients with known breast health.

Breast Cancer

Weill Medical College of Cornell University200 participantsStarted Mar 2005

New York, New York, United States

COMPLETEDPHASE312 miles

Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

NCT00081796

The purpose of this clinical trial is to determine if RPR109881 is a better treatment than capecitabine (Xeloda) for advanced breast cancer in patients that no longer benefit from docetaxel and/or paclitaxel.

Breast CancerMetastases

Sanofi438 participantsStarted Apr 2004

Birmingham, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +184 more locations

Infrared Imaging (Breast Scan IR) for Early Breast Cancer Detection

Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

Breast Cancer Trials in Other Cities

Other Conditions in New York